1. Home
  2. BBSI vs SLDB Comparison

BBSI vs SLDB Comparison

Compare BBSI & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

SELL

Current Price

$32.59

Market Cap

818.9M

ML Signal

SELL

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$5.52

Market Cap

781.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBSI
SLDB
Founded
1965
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
818.9M
781.7M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
BBSI
SLDB
Price
$32.59
$5.52
Analyst Decision
Buy
Strong Buy
Analyst Count
3
14
Target Price
★ $40.75
$18.71
AVG Volume (30 Days)
210.5K
★ 1.4M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
★ 0.99%
N/A
EPS Growth
5.05
★ 34.97
EPS
★ N/A
N/A
Revenue
★ $920,432,000.00
$8,094,000.00
Revenue This Year
$3.97
N/A
Revenue Next Year
$5.34
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 9.50
N/A
52 Week Low
$25.33
$3.79
52 Week High
$42.47
$11.45

Technical Indicators

Market Signals
Indicator
BBSI
SLDB
Relative Strength Index (RSI) 49.78 24.03
Support Level $31.78 $5.52
Resistance Level $34.82 $7.42
Average True Range (ATR) 0.87 0.36
MACD 0.21 -0.11
Stochastic Oscillator 71.75 10.71

Price Performance

Historical Comparison
BBSI
SLDB

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of business management solutions for small and mid-sized companies through a platform that combines management consulting expertise with human resource tools to help business owners manage and operate their businesses more effectively. The company has two categories of services: Professional Employer Services (PEO) and Staffing. The majority of revenue is derived from the Professional Employer Services segment, which provides clients with human resource advisory services, HRIS access, retirement plans, a learning management system, and a web-based technology platform, myBBSI.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: